KIAWAH ISLAND, S.C. — At the Kiawah Eye meeting, Steve Charles, MD, discusses different techniques for performing vitreomacular surgery.
Analysis: Eylea, Lucentis less cost-effective than Avastin for treatment of DME
Aflibercept and ranibizumab were less cost-effective than bevacizumab in the treatment of diabetic macular edema, according to a post hoc analysis of data from the Diabetic Retinopathy Clinical Research Network Protocol T trial.“These results highlight the challenges that physicians, patients and policymakers face when safety and efficacy results are at odds with cost-effectiveness results,” the study authors said.
AMA, ACP, others urge CMS to reconsider interoperability measurements for EHRs
The AMA, along with 36 other medical societies, is petitioning CMS and the Office of the National Coordinator for Health Information Technology for changes to how it measures interoperability of electronic health records.According to an AMA press relea…
Early data ‘promising’ for gene therapy for Leber’s hereditary optic neuropathy
GenSight Biologics reported “promising” preliminary data on its gene therapy product for the treatment of neurodegenerative retinal disease, according to a press release.The study included 15 patients with Leber’s hereditary optic neuropathy (LHON) grouped into five groups, with each group of three patients receiving an escalating dose of GS010 via single intravitreal injection in the more severely affected eye. Mean onset of disease was 6 years. Enrollment in the phase 1/2 safety and tolerability study was completed in April 2015.
Study captures interactions of HIV-infected immune cells in living animal
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral partic…
Disease that causes blindness in children tied to new gene
Northwestern Medicine and University of Wisconsin-Madison (UW) scientists have identified a gene that causes severe glaucoma in children.